Admin Control Panel

New Post | Settings | Change Layout | Edit HTML | Edit posts | Sign Out


March20 podcast Dr Hazen
anti-TMA pill in a year or 2 ? (scroll 12 mins)

Additional info:
MEBO Karen
at UK Findacure conf 2020

Scroll down and select country

MEBO Map Testing & Meetups

Full details :
want listed ? contact

MEBO - UBIOME study 2018



MEBO Gut Microbiome Study
"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"
Funded by uBiome Research Grant

"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"

Dynamics of the Gut Microbiota in
Idiopathic Malodor Production

Started May 2018 - Ongoing

Current people sent kits : 100/100
3 kits per person


Participation info : LINK English

MEBO Private Facebook Group
to join : go to
or contact
Join/Watch the weekly
BO Sufferers Podcasts



TMAU Petition world
TMAU UK end total:262
TMAU UK ends 23/01/20
TMAU Petition USA end total 204
USA : Moveon open
TMAU (Dominican)
Metabolomic Profiling Study

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned

Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
NORD Member Organization
See RareConnect TMAU

Popular Posts (last 30 days)

Upcoming get-togethers

Let us know if you want a meetup listed
Follow MeBOResearch on Twitter

Blog Archive

MEBO Metabolic Malodor Survey (international) for Dr Hazen click here
click to Read more/less

survey for ANYONE who identifies with METABOLIC MALODOR

begun : Oct20
end : no ending for now

Regular readers will know that Dr Stan Hazen et al at Cleveland Clinic are developing a TMA-blocker pill, as they proposed in a 2011 paper that TMAO is a factor in CVD. Recently Dr Hazen and colleagues contacted MEBO as they have always thought they could also help with TMAU. This survey is to give them an idea of the 'state of the community'. It is a "version 1". They may not even look (though they have access permission), but it could be useful to give them an overview of the community

MEBO had a zoom call with Dr Hazen and his team in October. Another zoom call is planned when they have time

This is a GOOGLE FORMS survey

short url for survey :

current participants : 113 (update 18dec20)

Friday, August 16, 2019

Polish study : Does TMA not TMAO cause CVD ?

A Polish lab this week published a paper saying in the study they did in rats, that Trimethylamine seemed to be related with smooth muscle damage in rats, rather than TMA-oxide.

This is obviously of great interest to the TMAU community because :
1. It would mean TMA would be associated with heart disease.
2. It might mean more anti-TMA therapies i nthe future (if not already on the way).

TMA-oxide and Heart Disease
In 2011, Cleveland Clinic Heartlab first suggested the hypothesis ... TMA-oxide is a BIOMARKER and CAUSE of damage that leads to HEART DISEASE etc.
This small Polish study suggests in rats it's TMA that is the BIOMARKER and perhaps a CAUSE, rather than TMAO.

What to think ?
This is the way research goes. One lab says one thing and another says another.
e.g. The way studies say butter is good (or bad ) for you.
Then over time a consensus is decided (e.g. climate change or not ?).

So for now the 'TMA - CVD' theory could be a blip or the correct theory, or neither ??

Polish lab
It's good to see a Polish lab interested in TMA and TMA-oxide.

Leaky Gut 
Also interesting to see LEAKY GUT get a mention in the study.
They say older rats more prone to 'leaky gut', leading to more TMA absorption (??).   

Poland study Aug 2019
TMA but not TMAO increases with age in rat plasma and affects smooth muscle cells viability

Quote ...
In vitro, TMA at concentration of 500 µmol/L (2-fold higher than in portal blood) decreased hVSMCs viability. In contrast, TMAO at 1000-fold higher concentration than physiological one, had no effect on hVSMCs viability. In conclusion, older rats show higher plasma level of TMA due to a “leaky gut”. TMA but not TMAO affects hVSMCs viability. We propose that TMA but not TMAO may be a marker and mediator of cardiovascular risk.     

Upcoming Anti-TMA pill made by Procter and Gamble 
P&G in association with Cleveland Heartlab will be producing an 'over-the counter' TMA-inhibiting supplement in the future.
It is unknown when it will market.
Speculation to the supplement reaching market could be from 2020 to maybe 2023 or later.
It's top secret and nothing is told to MEBO.

get New Posts by EMAIL : Enter your email address :

A EURORDIS and NORD Member Organization


Unknown said...

I cant wait to have that pill here in winnipeg canada. I hope it is over the counter and no need for prescription of a doctor. If anyone is updated about this pikl please let me know i want to know more about thi pill. And if it can really make my body odor gone for good. And do i have to take it for a lifetime?

Aug 16, 2019, 8:46:00 PM
Post a Comment